氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (2255 KB) HTML (29 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Amlodipine Besylate and Atorvastatin Calcium Tablets in treatment of hypertension complicated with coronary heart disease.Methods A total of 80 patients with hypertension complicated with coronary heart disease who treated in our hospital from August 2015 to March 2017 were selected as subjects,and were divided into two groups according to the random digital table method,with 40 cases in each group.The control group were received the Atorvastatin Calcium Tablets treatment,while the study group were received Amlodipine Besylate and Atorvastatin Calcium Tablets treatment.The therapeutic effect,blood pressure,blood lipid and inflammatory factors before and after treatment of the two groups were compared.Results The total effective rate of the patients in the study group(92.50%)was higher than that in the control group(77.50%),and the difference was statistically significant(P＜0.05).Before treatment,the SBP,DBP,HDL-C,LDL-C,TG,TC,ET,NO,vWF,TNF-α,IL-6 and CRP in the two groups were compared,and the differences were not statistically significant(P＞0.05).After treatment,the HDL-C and ET of the two groups were compared,and the differences were not statistically significant(P＞0.05),while the SBP,DBP,LDL-C,TG,TC,vWF,TNF-α,IL-6 and CRP in the study group were both lower than those in the control group,the NO was higher than that in the control group,and the differences were statistically significant(P＜0.05).Conclusion The Amlodipine Besylate and Atorvastatin Calcium Tablets in treatment of hypertension complicated with coronary heart disease which can significantly improve the blood pressure,heart rate and other indicators,and can relieve the symptoms of the disease,and the clinical effect are outstanding,to achieve the purpose of improving the quality of life,thus it is worth of application and promotion.

Key words： Coronary heart disease Hypertension Amlodipine Atorvastatin Calcium Tablets

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHONG Jie-zhu

Cite this article:

ZHONG Jie-zhu. Clinical effect of Amlodipine Besylate and Atorvastatin Calcium Tablets in treatment of hypertension complicated with coronary heart disease[J]. 中国当代医药, 2018, 25(10): 150-153.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I10/150

[1]	梅光艳，李杰.氨氯地平阿托伐他汀钙片对高血压合并冠心病患者血压、血脂水平的影响[J].实用临床医药杂志，2016，20（3）：131-132.
[2]	刘宏涛.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床疗效分析[J].中国实用医药，2017，12（28）：118-119.
[3]	刘江生.康复心脏病学[M].1版.北京：中国科学技术出版社，1996：271.
[4]	中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志，2011，39（7）：701-708.
[5]	郑筱萸.中医新药临床研究指导原则（试行）[M].北京：中国医药科技出版社，2002.
[6]	陈明，王培宁，杨新春，等.原发性高血压合并冠心病患者脉压与急性心肌梗死的关系[J].中华心血管病杂志，2005，33（S1）：199-200.
[7]	曹秀伟.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的疗效观察[J].中西医结合心血管病电子杂志，2015，3（2）：28-29.
[8]	刘玉英，张彬，王木华，等.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的疗效观察[J].中国医药导刊，2016，18（9）：927-928.
[9]	Rosendorff C，Lackland D，Allison M，et al.Treatment of hypertension in patients with coronary artery disease：a scientific statement from the American Heart Association，American College of Cardiology Foundation，and American Society of Hypertension[J].J Amer Soc Hypertension，2015，9（6）：435-470.
[10]	黄益花.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病护理分析[J].中国生化药物杂志，2017，37（11）：264-266.
[11]	林美明，余新，卢仁荣，等.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的疗效探讨[J].中外医疗，2016，35（25）：114-116.
[12]	漆军华.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床价值[J].河北医学，2012，18（6）：835-837.
[13]	杨书文，张晏，付静，等.氨氯地平阿托伐他汀钙片对高血压合并冠心病的临床疗效分析[J].现代生物医学进展，2013，13（1）：116-118.
[14]	梅光艳，李杰.氨氯地平阿托伐他汀钙片对高血压合并冠心病患者血压、血脂水平的影响[J].实用临床医药杂志，2016，20（3）：131-132.
[15]	陈节.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病疗效观察[J].陕西医学杂志，2016，45（12）：1675-1676.